Literature DB >> 10590082

T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.

B C Godthelp1, M J van Tol, J M Vossen, P J van Den Elsen.   

Abstract

To evaluate the role of T-cell selection in the thymus and/or periphery in T-cell immune reconstitution after allogeneic bone marrow transplantation (allo-BMT), we have analyzed the overall and antigen-specific T-cell repertoires in pediatric allo-BMT recipients treated for leukemia. We observed a lack of overall T-cell receptor (TCR) diversity in the repopulating T cells at 3 months after allo-BMT, as was deduced from complementarity determining region 3 (CDR3) size distribution patterns displaying reduced complexity. This was noted particularly in recipients of a T-cell-depleted (TCD) graft and, to a lesser extent, also in recipients of unmanipulated grafts. At 1 year after allo-BMT, normalization was observed of TCR CDR3 size complexity in almost all recipients. Analysis of the antigen-specific T-cell repertoire at 1 year after BMT showed that the T cells responding to tetanus toxoid (TT) differed in TCR gene segment usage and in amino acid composition of the CDR3 region when comparing the recipient with the donor. Moreover, the TT-specific TCR repertoire was found to be stable within a given allo-BMT recipient, because TT-specific T cells with completely identical TCRs were found at 3 consecutive years after transplantation. These observations suggest an important role for T-cell selection processes in the complete restoration of the T-cell immune repertoire in children after allo-BMT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590082

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Authors:  Ursula Hainz; Petra Obexer; Christiana Winkler; Peter Sedlmayr; Osamu Takikawa; Hildegard Greinix; Anita Lawitschka; Ulrike Pötschger; Dietmar Fuchs; Stephan Ladisch; Andreas Heitger
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

2.  Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

Authors:  David A Jacobsohn; Mukta Arora; John P Klein; Anna Hassebroek; Mary E Flowers; Corey S Cutler; Alvaro Urbano-Ispizua; Brian J Bolwell; Joseph H Antin; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Roger H Herzig; Luis M Isola; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Robert P Gale; Harry C Schouten; Stephen R Spellman; Daniel J Weisdorf; John R Wingard; Mary M Horowitz; Steven Z Pavletic
Journal:  Blood       Date:  2011-08-30       Impact factor: 22.113

3.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

4.  Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.

Authors:  Jan Storek; Zhao Zhao; Yiping Liu; Richard Nash; Peter McSweeney; David G Maloney
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

5.  The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation.

Authors:  Hiroyasu Inoue; Yukiharu Yasuda; Kinya Hattori; Takashi Shimizu; Masae Matsumoto; Miharu Yabe; Hiromasa Yabe; Fumiko Tsuchida; Yumiko Tanaka; Gaku Hosoi; Masahiro Sako; Shunichi Kato
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

6.  Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Authors:  Karim Sacre; Stéphanie Nguyen; Claire Deback; Guislaine Carcelain; Jean-Paul Vernant; Véronique Leblond; Brigitte Autran; Nathalie Dhedin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

Review 7.  Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Ronald E Gress
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 8.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

Review 9.  The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.

Authors:  Ioannis Politikos; Vassiliki A Boussiotis
Journal:  Blood       Date:  2014-10-06       Impact factor: 22.113

10.  The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.

Authors:  Atar Lev; Amos J Simon; Mor Bareket; Bella Bielorai; Daphna Hutt; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.